Examining the Effects of Mitochondrial Oxidative Stress in DCM
Status:
Not yet recruiting
Trial end date:
2025-07-03
Target enrollment:
Participant gender:
Summary
Double blind, randomised, placebo-controlled trial of MitoQ (mitoquinol mesylate) in 106
patients with dilated cardiomyopathy, examining the effect of reducing mitochondrial
oxidative stress on myocardial energetics and myocardial function using 31-phosphorus
magnetic resonance spectroscopy and cardiovascular magnetic resonance.